Industry
[Bio Startup] Avellino Labs aims to set example for Kosdaq listing of US firms
June 30, 2019
Thinking of undergoing vision-sharpening surgery but scared if things would go awry as you grow older? Taking cue of such concerns among people contemplating lasik surgery, genetic services provider Avellino Labs, headquartered in Palo Alto, California, has developed a DNA diagnostic kit which the company claims has protected 1,108 people from blindness as of June 2019 from the 743,969 patients thus far tested.With the addition of coming keratoconus test, Avellino Labs can help millions of